Bertino JR - Search Results

1

Development of a retroviral construct containing a human mutated dihydrofolate reductase cDNA for hematopoietic stem cell transduction.

Li MX, Banerjee D, Zhao SC, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Li MX, et al. Among authors: bertino jr. Blood. 1994 Jun 1;83(11):3403-8. Blood. 1994. PMID: 8193378 Free article.

2

Long-term protection of recipient mice from lethal doses of methotrexate by marrow infected with a double-copy vector retrovirus containing a mutant dihydrofolate reductase.

Zhao SC, Li MX, Banerjee D, Schweitzer BI, Mineishi S, Gilboa E, Bertino JR. Zhao SC, et al. Among authors: bertino jr. Cancer Gene Ther. 1994 Mar;1(1):27-33. Cancer Gene Ther. 1994. PMID: 7621235

3

Transfection of a nonactive site mutant murine DHFR cDNA (the tryptophan 15 mutant) into Chinese hamster ovary and mouse marrow progenitor cells imparts MTX resistance in vitro.

Banerjee D, Zhao SC, Tong Y, Steinherz J, Gritsman K, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Cancer Gene Ther. 1994 Sep;1(3):181-4. Cancer Gene Ther. 1994. PMID: 7621249

4

Gene therapy utilizing drug resistance genes: a review.

Banerjee D, Zhao SC, Li MX, Schweitzer BI, Mineishi S, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Stem Cells. 1994 Jul;12(4):378-85. doi: 10.1002/stem.5530120404. Stem Cells. 1994. PMID: 7951004 Review.

5

Transfection with a cDNA encoding a Ser31 or Ser34 mutant human dihydrofolate reductase into Chinese hamster ovary and mouse marrow progenitor cells confers methotrexate resistance.

Banerjee D, Schweitzer BI, Volkenandt M, Li MX, Waltham M, Mineishi S, Zhao SC, Bertino JR. Banerjee D, et al. Among authors: bertino jr. Gene. 1994 Feb 25;139(2):269-74. doi: 10.1016/0378-1119(94)90768-4. Gene. 1994. PMID: 8112617

6

Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.

Dicker AP, Waltham MC, Volkenandt M, Schweitzer BI, Otter GM, Schmid FA, Sirotnak FM, Bertino JR. Dicker AP, et al. Among authors: bertino jr. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11797-801. doi: 10.1073/pnas.90.24.11797. Proc Natl Acad Sci U S A. 1993. PMID: 8265628 Free PMC article.

7

Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.

Ercikan-Abali EA, Waltham MC, Dicker AP, Schweitzer BI, Gritsman H, Banerjee D, Bertino JR. Ercikan-Abali EA, et al. Among authors: bertino jr. Mol Pharmacol. 1996 Mar;49(3):430-7. Mol Pharmacol. 1996. PMID: 8643082

8

Active site-directed double mutants of dihydrofolate reductase.

Ercikan-Abali EA, Mineishi S, Tong Y, Nakahara S, Waltham MC, Banerjee D, Chen W, Sadelain M, Bertino JR. Ercikan-Abali EA, et al. Among authors: bertino jr. Cancer Res. 1996 Sep 15;56(18):4142-5. Cancer Res. 1996. PMID: 8797582

9

Post-transplant methotrexate administration leads to improved curability of mice bearing a mammary tumor transplanted with marrow transduced with a mutant human dihydrofolate reductase cDNA.

Zhao SC, Banerjee D, Mineishi S, Bertino JR. Zhao SC, et al. Among authors: bertino jr. Hum Gene Ther. 1997 May 20;8(8):903-9. doi: 10.1089/hum.1997.8.8-903. Hum Gene Ther. 1997. PMID: 9195212

10

Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene.

Mineishi S, Nakahara S, Takebe N, Banerjee D, Zhao SC, Bertino JR. Mineishi S, et al. Among authors: bertino jr. Gene Ther. 1997 Jun;4(6):570-6. doi: 10.1038/sj.gt.3300439. Gene Ther. 1997. PMID: 9231073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

711 results

Search Page

Filters